HIGHLIGHTS
- who: Sonia E. Barberis from the Rhode Island Hospital, United States Columbia University, United States have published the research: Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the action of asclepain cI, the main purified protease of the latex of petioles and stems from A. curassavica L (Asclepiadaceae) against H. pylori, and thus obtain a natural therapeutic adjuvant and a safe nutraceutical product.
- how: The authors used H. pylori NCTC 11638 as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.